The newly formed IQN Path ASBL joined the Naples 2016 Congress stakeholders involved in promoting accurate testing for anti-cancer drug selection. The conference was organised by the Italian Association of Medical Oncology (AIOM) with the European Society of Pathology (ESP) and the Italian Association of Surgical Pathology (SIAPEC-IAP), and with the endorsement of the European read more…